- Dey, L.P. suit alleges Sepracor infringes multiple patents with
Brovana(TM) (arformoterol tartrate) Inhalation Solution for treatment of
COPD -
NAPA, Calif., Sept. 21 /PRNewswire/ -- Dey, L.P. announced that the
United States District Court of New York has issued a Scheduling Order
setting December 12, 2008 as the trial date for the Company's intellectual
property infringement suit against Sepracor for Brovana(TM) (arformoterol
tartrate) Inhalation Solution. DEY's suit seeks redress against Sepracor
for knowingly infringing multiple DEY patents through its marketing of
Brovana(TM), a treatment for Chronic Obstructive Pulmonary Diseases (COPD).
About Dey, L.P.
Dey, L.P. is a specialty pharmaceutical company focused on the
development, manufacturing and marketing of prescription drug products for
the treatment of respiratory diseases, respiratory-related allergies, and
emergency care medicine. As the US leader in nebulized respiratory
medication, DEY puts patients first through its development of innovative
and affordable therapies. The Web sites for DEY include http://www.dey.com,
http://www.accuneb.com, http://www.curosurfusa.com, http://www.cyanokit.com, http://www.duoneb.com,
http://www.epipen.com and http://www.perforomist.com. Dey, L.P. is an affiliate of Merck
KGaA, Darmstadt, Germany.
Media contacts: Dey, L.P. Media Line
1-800-755-5560 ext. 8363
or
Harriet Ullman
Feinstein Kean Healthcare
617-761-6776
hullman@fkhealth.com
SOURCE Dey, L.P.
 back to top
Related links:
http://www.dey.com
CONTACT:
Dey, L.P. Media Line, 1-800-755-5560 ext.
8363, or Harriet Ullman of Feinstein Kean Healthcare,
+1-617-761-6776, hullman@fkhealth.com, for Dey, L.P.
|
